New Research Holds Promise for treating Chagas disease
Fernando Villalta, Ph.D., chair of Microbiology and Immunology at Meharry, is first
author on a paper published in the Journal of Infectious Diseases that explains a
treatment that holds promise for treating Chagas disease.
Chagas disease is found mostly in Latin America, infecting nearly eight million people,
but the carrier of the infected parasite—an insect called the "kissing bug"—has been
found elsewhere in the world, including the southern United States.
Dr. Villalta's lab has researched the condition and reports that both the acute and
chronic forms of the infection were cured with a 100 percent survival rate in lab
test. read more
Guo Awarded Patent for Novel Drug Therapy
ZhongMao Guo, M.D., Ph.D., professor in Meharry's Department of Physiology and President
of the Tennessee Physiology Society, has been awarded a patent for a method of treating
atherosclerosis, a hardening of the arteries that occurs when fat, cholesterol and
other substances build up in the arteries and form hard struc-tures called plaques.
Patent number US 8, 143,265 B2 was awarded to Guo by the U.S. Patent and Trademark
Office earlier this year. Dr. Guo said his treatment method consists of a new drug
therapy, which could lead to prevention and treatment of heart disease and stroke.
Both conditions disproportionately affect African Americans.
Case Study Published in NEJM Finds Lung Damage in Soldiers
Matthew King M.D., assistant professor in the Division of Pulmonary and Critical Care
Medicine at Meharry, is lead author of a ground-breaking article published in the
New England Journal of Medicine.
The article titled "Constrictive Bronchiolitis in Soldiers Returning from Iraq and
Afghanistan," is a case study of lung damage found in soldiers who served in Iraq
King and Dr. Robert Miller, of Vanderbilt University Medical Center, spent six years
compiling a descriptive case series examining soldiers referred from the Ft. Campbell
military base in Kentucky who had shortness of breath.
King has testified before the U.S. Senate to raise awareness of the issue.